Skip to content

Evaluation of carotid artery plaque stability and prediction of stroke by ultrasonography

Evaluation of carotid artery plaque stability and prediction of stroke by ultrasonography

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021846
Enrollment
Unknown
Registered
2019-03-12
Start date
2016-01-01
Completion date
Unknown
Last updated
2019-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

carotid artery plaque stability

Interventions

Gold Standard:Pathological or MRI diagnosis
Index test:Gray-scale&#32
contrast-enhanced&#32
elastography

Sponsors

Department of ultrasound, Beijing Tiantan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients with asymptomatic carotid artery plaque formation, no stenosis or stenosis rate of 50-99%.Detailed records list age, gender, along with basic diseases, such as high blood pressure, diabetes, hyperlipidemia, coronary heart disease, smoking history and daily smoking, drug use, such as whether to take high blood pressure medicine, blood pressure control, was taken or not and whether regular medication, insulin injections or not, blood sugar control, statin dosage and whether regular use, dosage of aspirin and whether regular use, whether in the short term double resistance to treatment, etc., loss of visitor ruled out.Sign the informed consent.

Exclusion criteria

Exclusion criteria: Patients with intracranial arteriovenous malformations, intracranial arterial stenosis, occlusion and other cerebrovascular diseases, diseases of the immune system and severe cardiac and renal insufficiency were excluded. Atrial fibrillation, patent foramen ovalis, aortic arch plaques, recent inflammatory diseases and metal foreign body implantation were excluded.Hypercholesterolemia, polycythemia erythrocythemia and other diseases of the blood system and metabolic syndrome were excluded.

Design outcomes

Primary

MeasureTime frame
accuracy rate;sensitivity;specificity;

Countries

China

Contacts

Public ContactHe Wen

Department of ultrasound, Beijing Tiantan Hospital, Capital Medical University

ttyyus@sina.com+86 13910422910

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026